OG Anunoby

#8 SF

New York Knicks

Status

GTD - Hamstring Expected Return: 2024-10-01

Previous game (vs. IND 5/19)

PTS

REB

AST

BLK

STL

Latest OG Anunoby news

Anunoby intends to ink a five-year, $212.5 million contract extension with the Knicks, which includes a player option and trade kicker, Adrian Wojnarowski of ESPN reports. Anunoby's extension comes in the wake of the Knicks trading for Mikal Bridges, giving the team an excellent wing tandem heading into 2024-25. Anunoby was injured for much of his Knicks tenure last season, but he averaged 14.7 points, 5.0 rebounds, 1.5 assists, 1.5 steals and 1.0 blocks across 36.2 minutes during his 31 regular-season and playoff games, minus his five-minute final appearance in Game 7 of the second round against Indiana. His role should remain similar this upcoming season, especially with Julius Randle presumably returning healthy in addition to Bridges' addition.

2023-24 Postseason Stats

PTS

REB

AST

BLK

STL

15.1

6.0

1.1

1.0

0.9

1.1

2023-24 Season Stats

PTS

REB

AST

BLK

STL

14.7

4.2

2.1

0.7

1.4

1.6

Career Averages

PTS

REB

AST

BLK

STL

12.0

4.3

1.6

0.5

1.3

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2023-24	50	50	34.0	14.7	4.2	2.1	0.7	1.4	1.6	0	2.0	5.3	38.2%	3.6	6.2	58.1%	5.6	11.5	48.9%	1.3	1.8	75.3%	0.9	3.2	2.4	1.3	+390	59.5%
2022-23	67	67	35.6	16.8	5.0	2.0	0.7	1.9	2.0	2	2.1	5.5	38.7%	4.2	7.7	53.9%	6.3	13.2	47.6%	2.1	2.5	83.8%	1.4	3.5	3.0	1.0	+132	58.6%
2021-22	48	48	36.0	17.1	5.5	2.6	0.5	1.5	1.7	3	2.4	6.6	36.3%	4.0	7.9	51.1%	6.4	14.5	44.3%	1.9	2.5	75.4%	1.5	4.0	2.7	1.6	+138	54.9%
2020-21	43	43	33.3	15.9	5.5	2.2	0.7	1.5	1.7	3	2.4	6.1	39.8%	3.4	6.0	56.2%	5.8	12.1	48.0%	1.9	2.4	78.4%	1.3	4.3	2.7	1.3	+119	60.5%
2019-20	69	68	29.9	10.6	5.3	1.6	0.7	1.4	1.1	5	1.3	3.3	39.0%	2.9	4.9	58.3%	4.1	8.2	50.5%	1.0	1.5	70.6%	1.2	4.1	2.4	1.4	+273	60.0%
2018-19	67	6	20.2	7.0	2.9	0.7	0.3	0.7	0.8	0	1.0	3.0	33.2%	1.7	3.0	57.4%	2.7	6.0	45.3%	0.5	0.9	58.1%	0.9	2.1	2.1	0.9	-49	54.4%
2017-18	74	62	20.0	5.9	2.5	0.7	0.2	0.7	0.6	0	1.0	2.7	37.1%	1.2	2.0	60.4%	2.2	4.7	47.1%	0.5	0.8	62.9%	0.6	1.9	1.8	1.2	+291	58.7%
Career	418	344	29.1	12.0	4.3	1.6	0.5	1.3	1.3	13	1.7	4.4	37.6%	2.9	5.2	55.7%	4.5	9.6	47.4%	1.3	1.7	74.5%	1.1	3.2	2.4	1.2	+1294	58.1%

Career Averages

PTS

REB

AST

BLK

STL

12.1

4.9

1.3

0.8

0.9

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2023-24	9	9	36.0	15.1	6.0	1.1	1.0	0.9	1.1	1	1.8	4.3	41.0%	4.4	8.0	55.6%	6.2	12.3	50.5%	0.9	1.4	61.5%	0.8	5.2	1.7	1.0	+3	58.3%
2021-22	6	6	36.2	17.3	4.0	2.5	0.2	1.0	1.7	0	2.3	6.8	34.1%	4.2	6.8	61.0%	6.5	13.7	47.6%	2.0	2.7	75.0%	1.2	2.8	3.0	1.5	-31	58.4%
2019-20	11	11	35.7	10.5	6.9	1.2	1.2	1.0	1.5	2	1.5	3.7	41.5%	2.1	4.3	48.9%	3.6	8.0	45.5%	1.6	2.5	64.3%	2.4	4.5	2.5	0.8	+22	57.3%
2017-18	10	10	23.8	7.9	2.1	0.7	0.4	0.6	0.6	0	1.3	2.9	44.8%	1.6	2.3	69.6%	2.9	5.2	55.8%	0.8	1.1	72.7%	0.9	1.2	2.3	1.2	-23	69.5%
Career	36	36	32.6	12.1	4.9	1.3	0.8	0.9	1.2	3	1.7	4.2	40.0%	2.9	5.1	56.8%	4.6	9.3	49.2%	1.3	1.9	67.6%	1.4	3.5	2.3	1.1	-29	59.8%


Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/20	WAS	W 134-98	23	15	4	4	1	1	3	5	2	40.0%	5	4	80.0%	10	6	60.0%	1	1	100.0%	1	3	1.3	+11	2	17	71.8%
10/17	CHI	W 106-102	29	7	2	3	0	1	0	2	0	0.0%	3	2	66.7%	5	2	40.0%	5	3	60.0%	2	0	0.0	+9	3	9	48.6%
10/15	CNS	W 134-93	16	10	1	1	0	1	2	6	3	50.0%	0	0	0.0%	6	3	50.0%	2	1	50.0%	0	1	0.5	+19	1	7	72.7%
10/8	SAC	W 112-99	20	14	0	3	0	2	0	2	2	100.0%	5	4	80.0%	7	6	85.7%	0	0	0.0%	0	0	0.0	+14	0	18	100.0%
Preseason Totals			22.4	11.5	1.8	2.8	0.3	1.3	1.3	3.8	1.8	46.7%	3.3	2.5	76.9%	7.0	4.3	60.7%	2.0	1.3	62.5%	0.8	1.0	2.2	+53	1.5	14.3	73.0%


Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/14	CHI	W 120-119	42	11	5	4	1	2	6	4	2	50.0%	6	2	33.3%	10	4	40.0%	3	1	33.3%	2	3	0.7	+8	4	7	48.6%
4/12	BKN	W 111-107	33	15	1	0	0	2	0	5	3	60.0%	8	3	37.5%	13	6	46.2%	0	0	0.0%	0	1	0.0	+4	3	6	57.7%
4/11	BOS	W 118-109	25	12	5	1	1	1	1	3	2	66.7%	7	3	42.9%	10	5	50.0%	0	0	0.0%	1	4	1.0	+20	1	12	60.0%
4/9	CHI	W 128-117	35	24	3	1	1	0	2	6	4	66.7%	12	6	50.0%	18	10	55.6%	0	0	0.0%	0	3	0.5	+12	4	15	66.7%
4/7	MIL	W 122-109	37	4	3	2	2	4	1	5	0	0.0%	5	2	40.0%	10	2	20.0%	0	0	0.0%	2	1	2.0	+7	4	2	20.0%
4/5	CHI	L 108-100	28	12	1	0	0	2	1	4	2	50.0%	4	3	75.0%	8	5	62.5%	0	0	0.0%	0	1	0.0	+5	1	10	75.0%
3/16	SAC	W 98-91	33	2	6	2	3	1	3	4	0	0.0%	4	1	25.0%	8	1	12.5%	0	0	0.0%	1	5	0.7	+6	2	1	12.5%
3/14	POR	W 105-93	35	12	9	2	0	2	2	4	1	25.0%	7	4	57.1%	11	5	45.5%	2	1	50.0%	2	7	1.0	+11	4	12	50.5%
3/12	PHI	W 106-79	28	14	4	2	0	1	3	5	2	40.0%	6	4	66.7%	11	6	54.5%	0	0	0.0%	0	4	0.7	+28	0	13	63.6%
1/27	MIA	W 125-109	33	19	1	4	0	2	1	5	2	40.0%	9	6	66.7%	14	8	57.1%	3	1	33.3%	0	1	4.0	+13	2	15	62.0%
1/25	DEN	W 122-84	29	26	2	1	0	6	1	9	3	33.3%	9	7	77.8%	18	10	55.6%	5	3	60.0%	0	2	1.0	+38	2	24	64.4%
1/23	BKN	W 108-103	33	10	5	1	2	4	3	1	0	0.0%	7	3	42.9%	8	3	37.5%	4	4	100.0%	1	4	0.3	+11	2	12	51.2%
1/20	TOR	W 126-100	36	14	7	1	3	1	1	3	0	0.0%	8	5	62.5%	11	5	45.5%	4	4	100.0%	0	7	1.0	+20	2	22	54.9%
1/18	WAS	W 113-109	42	19	7	1	2	0	1	5	3	60.0%	4	3	75.0%	9	6	66.7%	4	4	100.0%	0	7	1.0	+12	3	24	88.3%
1/17	HOU	W 109-94	43	15	5	0	1	4	1	5	2	40.0%	5	3	60.0%	10	5	50.0%	3	3	100.0%	0	5	0.0	+24	2	17	66.3%
1/15	ORL	L 98-94	43	17	2	4	0	0	2	4	3	75.0%	7	2	28.6%	11	5	45.5%	4	4	100.0%	1	1	2.0	+2	2	13	66.6%
1/13	MEM	W 106-94	31	18	5	2	4	1	4	4	1	25.0%	11	6	54.5%	15	7	46.7%	4	3	75.0%	2	3	0.5	+7	1	18	53.7%
1/11	DAL	L 128-124	38	10	6	2	2	0	1	6	1	16.7%	4	3	75.0%	10	4	40.0%	1	1	100.0%	1	5	2.0	+14	1	12	47.9%
1/9	POR	W 112-84	29	23	4	0	1	1	1	6	4	66.7%	6	5	83.3%	12	9	75.0%	2	1	50.0%	2	2	0.0	+26	3	23	89.3%
1/6	WAS	W 121-105	31	9	5	2	0	1	1	3	1	33.3%	4	3	75.0%	7	4	57.1%	0	0	0.0%	2	3	2.0	+11	3	10	64.3%
1/5	PHI	W 128-92	37	11	2	0	0	1	0	3	1	33.3%	8	2	25.0%	11	3	27.3%	4	4	100.0%	1	1	0.0	+20	3	2	43.1%
1/3	CHI	W 116-100	34	11	8	2	0	2	1	4	1	25.0%	5	4	80.0%	9	5	55.6%	0	0	0.0%	2	6	2.0	+35	2	17	61.1%
1/1	MIN	W 112-106	35	17	6	1	0	2	1	6	3	50.0%	6	4	66.7%	12	7	58.3%	0	0	0.0%	3	3	1.0	+19	6	14	70.8%
12/29	BOS	L 120-118	37	12	2	2	0	2	1	4	2	50.0%	4	3	75.0%	8	5	62.5%	0	0	0.0%	0	2	2.0	+4	1	14	75.0%
12/27	WAS	W 132-102	29	26	6	2	0	0	1	7	3	42.9%	9	8	88.9%	16	11	68.8%	2	1	50.0%	2	4	2.0	+24	1	28	77.0%
12/23	UTA	L 126-119	35	19	2	4	0	2	0	3	2	66.7%	10	6	60.0%	13	8	61.5%	1	1	100.0%	1	1	0.0	-4	1	21	70.7%
12/22	PHI	L 121-111	34	12	4	6	0	1	2	4	0	0.0%	5	4	80.0%	9	4	44.4%	4	4	100.0%	0	4	3.0	-11	4	14	55.8%
12/20	DEN	L 113-104	39	9	1	3	0	0	1	4	1	25.0%	5	3	60.0%	9	4	44.4%	0	0	0.0%	0	1	3.0	-5	2	5	50.0%
12/18	CHA	W 114-99	32	5	2	2	0	1	2	5	0	0.0%	5	2	40.0%	10	2	20.0%	1	1	100.0%	0	2	1.0	+3	3	3	23.9%
12/15	ATL	L 125-104	32	7	2	4	0	0	2	4	1	25.0%	4	2	50.0%	8	3	37.5%	0	0	0.0%	0	2	2.0	-19	0	5	43.8%
12/13	ATL	W 135-128	36	22	5	3	0	1	2	5	2	40.0%	8	8	100.0%	13	10	76.9%	0	0	0.0%	2	3	1.5	+17	4	22	84.6%
12/11	NYK	L 136-130	36	29	5	2	0	1	2	11	5	45.5%	9	6	66.7%	20	11	55.0%	2	2	100.0%	1	4	1.0	-6	3	25	69.4%
12/8	CHA	L 119-116	36	11	3	4	0	1	0	6	0	0.0%	6	3	50.0%	12	3	25.0%	5	5	100.0%	0	3	0.0	+0	3	9	38.7%
12/6	MIA	L 112-103	39	23	8	6	1	1	2	10	5	50.0%	3	3	100.0%	13	8	61.5%	2	2	100.0%	1	7	3.0	-9	2	32	82.9%
12/1	NYK	L 119-106	27	9	5	3	2	1	3	6	1	16.7%	7	3	42.9%	13	4	30.8%	0	0	0.0%	1	4	1.0	-4	5	3	34.6%
11/29	PHX	W 112-105	33	13	3	1	1	3	0	5	3	60.0%	5	2	40.0%	10	5	50.0%	1	0	0.0%	0	3	0.0	+1	3	13	62.3%
11/28	BKN	L 115-103	36	10	3	2	0	0	2	6	2	33.3%	6	2	33.3%	12	4	33.3%	0	0	0.0%	2	1	1.0	-14	3	2	41.7%
11/26	CLE	L 105-102	34	11	7	1	1	0	1	5	2	40.0%	7	2	28.6%	12	4	33.3%	3	1	33.3%	5	2	1.0	+11	1	9	41.3%
11/24	CHI	W 121-108	33	26	6	3	0	1	2	7	5	71.4%	7	5	71.4%	14	10	71.4%	2	1	50.0%	1	5	1.5	+9	2	28	87.4%
11/22	IND	W 132-131	36	13	4	3	0	1	2	4	1	25.0%	8	4	50.0%	12	5	41.7%	2	2	100.0%	2	2	1.5	-6	3	9	50.5%
11/21	ORL	L 126-107	30	11	1	4	3	0	4	5	3	60.0%	3	1	33.3%	8	4	50.0%	0	0	0.0%	0	1	1.0	-15	0	10	68.8%
11/19	DET	W 142-113	26	9	5	3	0	2	1	6	1	16.7%	5	1	20.0%	11	2	18.2%	6	4	66.7%	1	4	3.0	+15	3	7	33.0%
11/11	BOS	L 117-94	27	8	3	2	0	1	0	8	2	25.0%	5	1	20.0%	13	3	23.1%	0	0	0.0%	1	2	0.0	-26	0	4	30.8%
11/8	DAL	W 127-116	35	26	5	2	0	0	2	8	3	37.5%	9	6	66.7%	17	9	52.9%	6	5	83.3%	1	4	1.0	+9	4	20	66.2%
11/5	SAS	W 123-116	38	24	6	4	0	2	1	13	7	53.8%	3	1	33.3%	16	8	50.0%	4	1	25.0%	2	4	4.0	+8	3	21	67.6%
11/2	PHI	L 114-99	32	16	4	1	1	0	3	4	2	50.0%	8	5	62.5%	12	7	58.3%	0	0	0.0%	1	3	0.3	+5	2	11	66.7%
11/1	MIL	W 130-111	24	16	2	3	0	1	2	1	1	100.0%	6	6	100.0%	7	7	100.0%	2	1	50.0%	0	2	1.5	+16	5	15	101.5%
10/30	POR	L 99-91	30	10	3	1	1	2	2	9	2	22.2%	3	2	66.7%	12	4	33.3%	0	0	0.0%	0	3	0.5	+0	0	8	41.7%
10/27	CHI	L 104-103	27	11	3	0	0	2	1	4	1	25.0%	4	4	100.0%	8	5	62.5%	1	0	0.0%	0	3	0.0	+28	2	10	65.2%
10/25	MIN	W 97-94	33	20	6	1	3	2	2	9	4	44.4%	4	3	75.0%	13	7	53.8%	2	2	100.0%	0	6	0.5	+6	2	24	72.0%
Regular Season Totals			34.0	14.7	4.2	2.1	0.7	1.4	1.6	5.3	2.0	38.2%	6.2	3.6	58.1%	11.5	5.6	48.9%	1.8	1.3	75.3%	0.9	3.2	1.3	+390	2.4	16.6	59.5%


Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
5/19	IND	L 130-109	4	5	0	0	0	0	0	1	1	100.0%	1	1	100.0%	2	2	100.0%	0	0	0.0%	0	0	0.0	-6	0	5	125.0%
5/8	IND	W 130-121	27	28	4	3	1	0	0	7	4	57.1%	12	6	50.0%	19	10	52.6%	6	4	66.7%	1	3	0.0	+10	1	27	64.7%
5/6	IND	W 121-117	42	13	9	4	0	2	2	7	3	42.9%	7	2	28.6%	14	5	35.7%	0	0	0.0%	0	9	2.0	+12	1	14	46.4%
5/2	PHI	W 118-115	45	19	9	0	2	2	1	5	2	40.0%	12	6	50.0%	17	8	47.1%	3	1	33.3%	1	8	0.0	+8	3	17	51.9%
4/30	PHI	L 112-106	50	17	6	0	1	2	4	5	2	40.0%	7	5	71.4%	12	7	58.3%	2	1	50.0%	1	5	0.0	-10	3	14	66.0%
4/28	PHI	W 97-92	46	16	14	0	3	0	1	4	0	0.0%	12	8	66.7%	16	8	50.0%	0	0	0.0%	2	12	0.0	+3	3	24	50.0%
4/25	PHI	L 125-114	39	17	4	2	1	1	1	4	3	75.0%	7	4	57.1%	11	7	63.6%	0	0	0.0%	1	3	2.0	-10	2	17	77.3%
4/22	PHI	W 104-101	36	10	4	1	1	0	0	3	0	0.0%	7	4	57.1%	10	4	40.0%	2	2	100.0%	0	4	0.0	+1	0	13	46.0%
4/20	PHI	W 111-104	31	11	4	0	0	1	1	3	1	33.3%	7	4	57.1%	10	5	50.0%	0	0	0.0%	1	3	0.0	-5	2	8	55.0%
Postseason Totals			36.0	15.1	6.0	1.1	1.0	0.9	1.1	4.3	1.8	41.0%	8.0	4.4	55.6%	12.3	6.2	50.5%	1.4	0.9	61.5%	0.8	5.2	1.0	+3	1.7	17.9	58.3%

OG Anunoby

#8 SF

Status

Previous game (vs. IND 5/19)

Latest OG Anunoby news

To sign five-year extension with NY

2023-24 Postseason Stats

2023-24 Season Stats

OG Anunoby Career Stats

Career Averages

Career Averages

OG Anunoby Season Stats 2023-24

Previous Game (vs. CHI 4/14)

2023-24 Stats

2023-24 Rebounding

2023-24 Defensive

2023-24 Shooting

2023-24 Advanced

2023-24 Stats

2023-24 Rebounding

2023-24 Defensive

2023-24 Shooting

2023-24 Advanced

OG Anunoby Game Log 2023-24

OG Anunoby Player Profile

Career History

OG Anunoby Fantasy Projections

It's the offseason! 😎

OG Anunoby Latest News

To sign five-year extension with NY

Declines player option Monday

Unlikely to return Sunday

Will start Sunday

On track to play

Upgraded to questionable

Ruled out for Game 6

Likely out for Game 6

Likely out for remainder of series

OG Anunoby

#8 SF

Unlock the latest New York Knicks news — direct to your inbox.

Status

Previous game (vs. IND 5/19)

Latest OG Anunoby news Subscribe

2023-24 Postseason Stats

2023-24 Season Stats

Latest OG Anunoby news